TMCnet News

Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017
[December 17, 2014]

Research and Markets: Global & USA Transdermal Drug Delivery Market to 2017


Research and Markets (http://www.researchandmarkets.com/research/tnkj5x/global_and_usa) has announced the addition of the "Global & USA Transdermal Drug Delivery Market to 2017" report to their offering.

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages.

This report is presented as follows:

  • By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)
  • By Geography (Global, USA)
  • By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems)
  • By Sub-market (Generics, Women's Health, Analgesics, Neuropathic Pain)

A wealth of financial data & business strategy information is provided including:

  • Up-to-date company financials, sales & revenue figures
  • Revenue and market forecasts
  • Business model strategies for drug delivery, pharmaceutical and biotechnology companies
  • Coprehensive account of company products, financials & portfolios



SWOT, Economic & Regulatory Environment specifics include:

  • Key strengths, weaknesses and threats influencing leading player position within the market
  • Technologies driving the market (e.g., chemical enhancers, microneedles)
  • Top fastest growing market segments and emerging opportunities
  • Top pharmaceutical companies within the market
  • Comprehensive product portfolios, R&D activity and pipeline products
  • M&A activity and future strategies of top companies
  • High demand and unmet need enhances the market
  • Challenges of the transdermal drug delivery market

Who should read this report?


  • Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
  • Industry professionals and business strategists will discover key information to propel their policies
  • Investors will gain inside information to dominant players in the industry and future forecasts
  • Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment C-Suite professionals, Decision Makers, Business Development professionals

This report will tell you if the companies mentioned are:

  • Strong, competitive players
  • Pooling their resources for specific growth and therapeutic areas
  • Investing strategically in R&D
  • Have a history of strategic M&A activity

Companies Mentioned

  • 3M (News - Alert)
  • AMAG Pharmaceuticals (Lumara Health, KV Pharm/Ther-Rx Corp)
  • Actavis
  • Actelion
  • Ascend Therapeutics
  • Bayer
  • Boehringer Ingelheim
  • Endo International
  • GlaxoSmithKline
  • Hercon Pharmaceutical
  • Janssen Pharmaceuticals
  • Kremers Urban Pharmaceuticals
  • Mylan Pharmaceuticals
  • Nitto Denko
  • Novartis
  • Noven Pharmaceuticals
  • ParPharm
  • ProStrakan
  • Shire
  • Teikoku USA
  • Teva Pharmaceutical Industries
  • UCB
  • Upsher-Smith

For more information visit http://www.researchandmarkets.com/research/tnkj5x/global_and_usa


[ Back To TMCnet.com's Homepage ]